4.8 (345) In stock
IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
Frontiers Heart failure and cancer: From active exposure to passive adaption
Cohort 1 (Early Effects Study): Baseline Characteristics in Groups
Mechanisms Of Myocardial Ischemia In Cancer Patients: A, 60% OFF
Frontiers D-Dimer Is Associated With Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease and Preserved Ejection Fraction
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Cardiomyocyte viability after ErbB2 inhibition. Fig a/b: Human
Cardio-Oncology
Vascular Regeneration in Peripheral Artery Disease Arteriosclerosis, Thrombosis, and Vascular Biology
Lenalidomide Algorithm Download Scientific Diagram
